Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
TK Owonikoko, MS Hossain, C Bhimani, Z Chen… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
TK Owonikoko, MS Hossain, C Bhimani, Z Chen, S Kim… - Cancer, 2013 - hero.epa.gov
BACKGROUND: Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
[引用][C] Soluble FAS Ligand as a Biomarker of Disease Recurrence in Differentiated Thyroid Cancer
TK OWONIKOKO, MS HOSSAIN, C BHIMANI… - Cancer, 2013 - pascal-francis.inist.fr
Soluble FAS Ligand as a Biomarker of Disease Recurrence in Differentiated Thyroid Cancer
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
TK Owonikoko, MS Hossain, C Bhimani, Z Chen… - Cancer, 2013 - pubmed.ncbi.nlm.nih.gov
Background Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
TK Owonikoko, MS Hossain, C Bhimani, Z Chen, S Kim… - Cancer, 2013 - infona.pl
BACKGROUND: Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.
TK Owonikoko, MS Hossain, C Bhimani, Z Chen, S Kim… - Cancer, 2013 - europepmc.org
Background Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
[HTML][HTML] Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
TK Owonikoko, MS Hossain, C Bhimani, Z Chen, S Kim… - Cancer, 2013 - ncbi.nlm.nih.gov
Background Reliable predictive biomarkers are required to address the challenge of
disease recurrence following thyroid cancer surgery. We assessed the association of …
disease recurrence following thyroid cancer surgery. We assessed the association of …
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.
TK Owonikoko, MS Hossain, C Bhimani, Z Chen, S Kim… - Cancer, 2013 - europepmc.org
Background Reliable predictive biomarkers are required to address the challenge of
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …
disease recurrence after thyroid cancer surgery. For this study, the authors assessed the …